The Anatomy of Addiction (22 page)

Kelly, J. F., & Yeterian, J. D. (2011). “The role of mutual-help groups in extending the framework of treatment.” Available at pubs.niaaa.nih.gov.

Keyes, K. M., Hatzenbuehler, M. L., McLaughlin, K. A., et al. (2010). “Stigma and treatment for alcohol disorders in the United States.”
American Journal of Epidemiology
172 (12): 1364–372.

Khantzian, E. J. (1985). “The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence.”
American Journal of Psychiatry
142 (11): 1259–264.

Kjome, K. L., & Moeller, F. G. (2011). “Long-acting injectable naltrexone for the management of patients with opioid dependence.”
Substance Abuse: Research and Treatment
5: 1–9.

Kleber, H. D., Weiss, R. D., Anton, R. F., et al. (2006). “Part A: Treatment of patients with substance use disorders, second edition.” American Psychiatric Association.
American Journal of Psychiatry
163 (Suppl. 8): 5–82.

Knudsen, H. K., Abraham, A. J., Johnson, J. A., & Roman, P. M. (2009). “Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network.”
Journal of Substance Abuse Treatment.

Knudsen, H. K., Abraham, A. J., & Oser, C. B. (2011). “Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure.”
Evaluation and Program Planning
34 (4): 375–81.

Kosten, T. R., & O'Connor, P. G. (2003). “Management of drug and alcohol withdrawal.”
New England Journal of Medicine
348 (18): 1786–795.

Krishnan-Sarin, S., Krystal, J. H., Shi, J., Pittman, B., & O'Malley, S. S. (2007). “Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.”
Biological Psychiatry
62 (6): 694–97.

Leshner, A. I. (1997). “Addiction is a brain disease, and it matters.”
Science
278 (5335): 45–47.

———. (1999). “Science is revolutionizing our view of addiction—and what to do about it.”

Lindborg, Kristina. (2014, March 28). “Why heroin is spreading in America's suburbs.”
Christian Science Monitor
. Available at http://www.csmonitor.com/USA/Society/2014/0323/Why-heroin-is-spreading-in-America-s-suburbs-video.

Ling, W., Charuvastra, C., Collins, J. F., et al. (1998). “Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial.”
Addiction
93 (4): 475–86.

Mangrum, L. F., Spence, R. T., & Lopez, M. (2006). “Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.”
Journal of Substance Abuse Treatment
30 (1): 79–84.

Miller, W. R., Sorensen, J. L., Selzer, J. A., & Brigham, G. S. (2006). “Disseminating evidence-based practices in substance abuse treatment: A review with suggestions.”
Journal of Substance Abuse.

Millery, M., Kleinman, B. P., Polissar, N. L., Millman, R. B., & Scimeca, M. (2002). “Detoxification as a gateway to long-term treatment: Assessing two interventions.”
Journal of Substance Abuse Treatment
23 (3): 183–90.

Milliken, C. S., Auchterlonie, J. L., & Hoge, C. W. (2007). “Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war.”
JAMA
298 (18): 2141–148.

Mroziewicz, M., & Tyndale, R. F. (2010). “Pharmacogenetics: A tool for identifying genetic factors in drug dependence and response to treatment.”
Addiction Science & Clinical Practice
5 (2): 17–29.

Munro, Dan. (2015, April 27). “Inside the $35 billion addiction treatment industry.”
Forbes
. Available at http://www.forbes.com/sites/danmunro/2015/04/27/inside-the-35-billion-addiction-treatment-industry.

Narconon International. (2011). History of marijuana. Available at www.narconon.org.

National Center on Addiction and Substance Abuse. (2012). CASAColumbia report.
Addiction Medicine: Closing the Gap between Science and Practice.
Results from a 5-year study
. Available at http://www.casacolumbia.org/addiction-research/reports/addiction-medicine.

National Institute on Drug Abuse. (2005). “Drug abuse and addiction: One of America's most challenging public health problems.” Available at www.nida.nih.gov.

National Institute on Drug Abuse. (2011). “Preventing and recognizing prescription drug abuse.” Available at www.nida.nih.gov.

National Institute on Drug Abuse. (2012). “Research report series: Heroin abuse and addiction: What are the treatments for heroin addiction?” Available at www.drugabuse.gov.

O'Brien, C. P. & McKay, J. (2007). “Psychopharmacological treatments for substance use disorders.” In P. E. Nathan & J. M. Gorman, eds.,
A Guide to Treatments That Work
(3rd ed., pp. 145–177). New York: Oxford University Press.

O'Connor, P. G. (2005). “Methods of detoxification and their role in treating patients with opioid dependence.”
JAMA
294 (8): 961–63.

O'Connor, P. G., Carroll, K. M., Shi, Ju. M., Schottenfeld, R. S., Kosten, T. R., & Rounsaville, B. J. (1997). “Three methods of opioid detoxification in a primary care setting: A randomized trial.”
Annals of Internal Medicine
127 (7): 526–30.

O'Connor, P. G., & Fiellin, D. A. (2000). “Pharmacologic treatment of heroin-dependent patients.”
Annals of Internal Medicine
133 (1): 40–54.

O'Connor, P. G., Nyquist, J. G., & McLellan, T. (2011). “Integrating addiction medicine into graduate medical education in primary care: The time has come.”
Annals of Internal Medicine
154 (1): 56–59.

O'Connor, P. J., & Youngstedt, S. D. (1995). “Influence of exercise on human sleep.”
Exercise and Sport Sciences Reviews
23 (1): 105–34.

O'Farrell, T. J., & Fals-Stewart, W. (2003). “Alcohol abuse.”
Journal of Marital and Family Therapy
29 (1): 121–46.

Patterson, T. L., & Jeste, D. V. (1999). “The potential impact of the baby-boom generation on substance abuse among elderly persons.”
Psychiatric Services
50(9): 1184–188.

Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010). “A disease like any other”? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence.”
American Journal of Psychiatry
167 (11): 1321–330.

Petrakis, I. L., Leslie, D., & Rosenheck, R. (2003). “Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.”
Alcoholism: Clinical and Experimental Research
27 (11): 1780–784.

Petrakis, I. L., Rosenheck, R., & Desai, R. (2011). “Substance use comorbidity among veterans with posttraumatic stress disorder
and other psychiatric illness.”
American Journal on Addictions
20 (3): 185–89.

Rieckmann, T. R., Kovas, A. E., Fussell, H. E., & Stettler, N. M. (2009). “Implementation of evidence-based practices for treatment of alcohol and drug disorders: The role of the state authority.”
Journal of Behavioral Health Services & Research
36 (4): 407–19.

Roan, S. (2008). “The 30-day myth.”
Los Angeles Times
. Available at articles.latimes.com.

Robert Wood Johnson Foundation. (2001).
Substance Abuse: The Nation's Number One Health Problem: Key Indicators for Policy Update
. Princeton, NJ.

SAMHSA's National Registry of Evidence-based Programs and Practices. (2007). “Motivational enhancement therapy (MET).” Available at nrepp.samhsa.gov.

SAMHSA's National Registry of Evidence-based Programs and Practices. (2008). “Multidimensional family therapy (MDFT)
.
” Available at nrepp.samhsa.gov.

SAMHSA's National Registry of Evidence-based Programs and Practices. (2007). “National Registry of Evidence-Based Programs and Practices (NREPP).” Available at nrepp.samhsa.gov.

Scheinholtz, M. K. (2011). “Implementation of evidence-based practices: SAMHSA's older adults targeted capacity expansion grant program.”
Journal of the American Society on Aging
34 (1): 26–35.

Schramm-Sapyta, N. L., Walker, Q. D., Caster, J. M., Levin, E. D., & Kuhn, C. M. (2009). “Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models.”
Psychopharmacology
206 (1): 1–21.

Seal, K. H., Cohen, G., Waldrop, A., Cohen, B. E., Maguen, S., & Ren, L.
(2011). “Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001–2010: Implications for screening, diagnosis and treatment.”
Drug and Alcohol Dependence
116 (1–3): 93–101.

Shen, X., Orson, F. M., & Kosten, T. R. (2011). “Anti-addiction vaccines.”
F1000. Medicine Report
3: 20.

Shorter, D., & Kosten, T. R. (2011). “Vaccines in the treatment of substance abuse.”
FOCUS: Journal of Lifelong Learning in Psychiatry
9 (1): 25–29.

Spohr, H. L., Willms, J., & Steinhausen, H. C. (1993). “Prenatal alcohol exposure and long-term developmental consequences.”
Lancet
341 (8850): 907–10.

Squeglia, L. M., Jacobus, J., & Tapert, S. F. (2009). “The influence of substance use on adolescent brain development.”
Clinical Electroencephalography and Neuroscience
40 (1): 31–38.

Squeglia, L. M., Spadoni, A. D., Infante, M. A., Myers, M. G., & Tapert, S. F. (2009). “Initiating moderate to heavy alcohol use predicts changes in neuropsychological functioning for adolescent girls and boys.”
Psychology of Addictive Behaviors
23 (4): 715–22.

Substance Abuse and Mental Health Services Administration. (2012)
.
“Co-occurring disorders in veterans and military service members.” Available at www.samhsa.gov.

Thomas, C. P., Reif, S., Haq, S., Wallack, S. S., Hoyt, A., & Ritter, G. A. (2008). “Use of buprenorphine for addiction treatment: Perspectives of addiction specialists and general psychiatrists.”

Timko, C., Moos, R. H., Finney, J. W., & Lesar, M. D. (2000). “Long-term outcomes of alcohol use disorders: Comparing untreated individuals with those in Alcoholics Anonymous
and formal treatment.”
Journal of Studies on Alcohol
61 (4): 529–40.

Tsuang, M. T., Bar, J. L., Harley, R. M., & Lyons, M. J. (2001). “The Harvard Twin Study of Substance Abuse: What we have learned.”
Harvard Review of Psychiatry
9 (6): 267–79.

Tsuang, M. T., Lyons, M. J., Harley, R. M., et al. (1999). “Genetic and environmental influences on transitions in drug use.”
Behavior Genetics
29 (6): 473–79.

U.S. Department of Justice, National Drug Intelligence Center. (2010). “Impact of drugs on society.” Available at www.justice.gov.

U.S. Department of Veteran Affairs, National Center for PTSD. (2011). “PTSD and problems with alcohol use.” Available at www.ptsd.va.gov.

U.S. House of Representatives, Office of the Legislative Counsel. (2010).
Compilation of Patient Protection and Affordable Care Act.
111th Cong., 2nd Sess. Print 111-111. Available at housedocs.house.gov.

University of Washington, Alcohol and Drug Abuse Institute. (2006). “Evidence-based practices for treating substance use disorders: Matrix of interventions.” Available at adai.washington.edu.

van den Bree, M. B., Johnson, E. O., Neale, M. C., & Pickens, R. W. (1998). “Genetic and environmental influences on drug use and abuse/dependence in male and female twins.”
Drug and Alcohol Dependency
52 (3), 231–41.

Van Hoof-Haines, K. (2012). “Dual diagnosis: The status of treating co-occurring disorders in the U.S.” Available at www.drugfree.org.

Volkow, N. D. (2007).
Drugs, Brains, and Behavior: The Science of
Addiction
[rev. August 2010] (NIH Pub. No. 10-5605). Rockville, MD: U.S. Department of Health and Human Services, National Institute on Drug Abuse.

Volkow, N. D., & Skolnick, P. (2012). “New medications for substance use disorders: Challenges and opportunities.”
Neuropsychopharmacology
37 (1): 290–92.

Watkins, K., Pincus, H. A., Tanielian, T. L., & Lloyd, J. (2003). “Using the chronic care model to improve treatment of alcohol use disorders in primary care settings.”
Journal of Studies on Alcohol,
64 (2), 209–18.

White, W., & Kurtz, E. (2005).
The Varieties of Recovery Experience: A Primer for Addiction Treatment Professionals and Recovery Advocates
. Chicago: Great Lakes Addiction Technology Transfer Center.

Wilk, J. E., Bliese, P. D., Kim, P. Y., Thomas, J. L., McGurk, D., & Hoge, C. W. (2010). “Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war.”
Drug and Alcohol Dependence
108 (1–2): 115–21.

Willenbring, M. L. (2008). “New research is redefining alcohol disorders: Does the treatment field have the courage to change?”
Addiction Professional
6 (5): 12–19.

World Health Organization. (2011). “Management of substance abuse. Lexicon of alcohol and drug terms published by the World Health Organization.” Available at www.who.int.

Yoast, R. A., Wilford, B. B., & Hayashi, S. W. (2008). “Encouraging physicians to screen for and intervene in substance use disorders: Obstacles and strategies for change.”
Journal of Addictive Diseases
27 (3): 77–97.

Yuferov, V., Levran, O., Proudnikov, D., Nielsen, D. A., & Kreek, M. J. (2010). “Search for genetic markers and functional
variants involved in the development of opiate and cocaine addiction and treatment.
Annals of the New York Academy of Sciences
1187: 184–207.

Zook, C. J., & Moore, F. D. (1980). “High-cost users of medical care.”
New England Journal of Medicine
302 (18): 996–
1002.